课题基金 / 基金详情

A Multi-Centre Non-Inferiority Randomized Controlled Trial of STOPping Cardiac MEDications in Patients with Normalized Cancer Therapy Related Cardiac Dysfunction - The STOP-MED CTRCD Trial

A Multi-Centre Non-Inferiority Randomized Controlled Trial of STOPping Cardiac MEDications in Patients with Normalized Cancer Therapy Related Cardiac Dysfunction - The STOP-MED CTRCD Trial
癌症治疗正常化相关心脏功能障碍患者停止心脏药物治疗的多中心非劣效随机对照试验 - STOP-MED CTRCD 试验
批准号：
473979
负责人：
Yu Christopher
金额：
$8.2万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-10-01 至 2025-04-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=473979&lang=en
关键词：
Cardiac Imaging Cardio-Oncology Cardiology Cardiomyopathy Cardiotoxicity Determine New Treatment Paradigms Improve Patient Outcomes Oncology Randomized Control Trial

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer therapy is associated with heart side effects. The most feared side effect is a reduction in heart function, which can affect up to 1 in 4 patients. When this occurs, heart medications are started to protect the heart from progressing to heart fail
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金